Cas:55492-86-9 2-(1,3-dithiol-2-ylidene)-1,3-dithiole,ditetrafluoroborate manufacturer & supplier

Chemical Name:2-(1,3-dithiol-2-ylidene)-1,3-dithiole,ditetrafluoroborate

CAS.NO:55492-86-9

Synonyms:Tetrathiafulvalene Fluoroborate;ditetrafluoroborate;T1282

Molecular Formula:C₁₈H₁₂B₂F₈S₁₂

Molecular Weight:786.678

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:315.36000

Exact Mass:785.765686

LogP:14.79260

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like Tetrathiafulvalene Fluoroborate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,T1282 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,T1282 Use and application,Tetrathiafulvalene Fluoroborate technical grade,usp/ep/jp grade.

Related News: Taiwan is denying entry to Chinese nationals from Guangdong, a southern coastal province that has also been battered by the virus, and travelers who have recently visited the area. 2-(1,3-dithiol-2-ylidene)-1,3-dithiole,ditetrafluoroborate manufacturer TSA notified airlines Saturday about the restrictions. CNN is reaching out to TSA for comment. 2-(1,3-dithiol-2-ylidene)-1,3-dithiole,ditetrafluoroborate supplier Vietnam recently barred almost all flights to and from mainland China, Hong Kong and Macau until May 1, according to the United States Federal Aviation Administration. 2-(1,3-dithiol-2-ylidene)-1,3-dithiole,ditetrafluoroborate vendor One key question for the fixed-duration combo is whether it can sustain remission after treatment has stopped. In the preliminary analysis of the GLOW trial, at three months after treatment ended, 51.9% of the Imbruvica-Venclexta patients had undetectable measurable residual disease (uMRD)—a stringent marker reflecting no signs of cancer—in bone marrow, versus 17.1% for the control group. The rates for peripheral blood were 54.7% and 39% for the two groups, respectively. 2-(1,3-dithiol-2-ylidene)-1,3-dithiole,ditetrafluoroborate factory Fate Therapeutics has exclusively licensed from MSK foundational intellectual property covering the production and composition of iPSC-derived T cells.